{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:48:38Z","timestamp":1791852518062,"version":"4.3.4"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,8]],"date-time":"2022-11-08T00:00:00Z","timestamp":1667865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,8]],"date-time":"2022-11-08T00:00:00Z","timestamp":1667865600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Antimicrob Resist Infect Control"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Antimicrobial resistance (AMR) in bacterial pathogens is a worldwide concern that demands immediate attention. Most information on AMR originates from high-income countries and little is known about the burden in Africa, particularly Nigeria. Using four sentinel sites (General hospitals) in Lagos State, this study sought to estimate the burden of AMR.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This is a hospital-based surveillance using secondary health care centres. Four sites were randomly selected and included in the study. Clinical isolates were collected over a period of 6 months for each site from August 2020 to March 2021. All isolates were characterised and analysed for resistance to 15 antibiotics using the Kirby-Baur method. Multiplex PCR assay was used for the detection of Extended spectrum beta lactamase genes. Data analysis was done using SPSS version 27.0.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Four hundred and ninety-nine (499) patients consented and participated in this study, consisting of 412 (82.6%) females and 87 (17.4%) males. The mean age\u2009\u00b1\u2009SD of the participants was 33.9\u2009\u00b1\u200913.8 with a range of 1\u201389 years. The majority (90.8%) of the participants were outpatients. Two hundred and thirty-two (232) isolates were obtained from 219 samples, comprising of 120 (51.7%) Gram positive and 112 (48.3%) Gram negative organisms. Key bacterial pathogens isolated from this study included <jats:italic>Staphylococcus aureus<\/jats:italic> (22.8%), <jats:italic>Escherichia coli<\/jats:italic> (16.4%), <jats:italic>Staphylococcus<\/jats:italic> spp. (15.9%), <jats:italic>Enterococcus<\/jats:italic> spp. (7.3%) and <jats:italic>Klebsiella pneumoniae<\/jats:italic> (6.5%). There was high prevalence of multi-drug resistance (79.3%) among the isolates with 73.6% of <jats:italic>Staphylococcus aureus<\/jats:italic> phenotypically resistant to methicillin and 70% possessed the <jats:italic>MecA<\/jats:italic> gene. 76.5% of <jats:italic>Enterococcus<\/jats:italic> spp. isolated were Vancomycin resistant. Overall, resistance to Cephalosporins was most frequently\/commonly observed (Cefotaxime 87.5%).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>A high incidence of AMR was identified in clinical bacteria isolates from selected general hospitals in Lagos State, highlighting the necessity for the implementation of national action plans to limit the prevalence of AMR. Surveillance via collection of isolates has a lot of promise, especially in resource-limited environments.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13756-022-01171-2","type":"journal-article","created":{"date-parts":[[2022,11,8]],"date-time":"2022-11-08T07:42:42Z","timestamp":1667893362000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["High prevalence of resistance to third-generation cephalosporins detected among clinical isolates from sentinel healthcare facilities in Lagos, Nigeria"],"prefix":"10.1186","volume":"11","author":[{"given":"Emelda E.","family":"Chukwu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oluwatoyin B.","family":"Awoderu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian A.","family":"Enwuru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ebelechukwu E.","family":"Afocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahman G.","family":"Lawal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahaman A.","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ishola","family":"Olanrewaju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chika K.","family":"Onwuamah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosemary A.","family":"Audu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Folasade T.","family":"Ogunsola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,8]]},"reference":[{"issue":"1","key":"1171_CR1","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1038\/nrmicro3380","volume":"13","author":"JMA Blair","year":"2015","unstructured":"Blair JMA, Webber MA, Baylay AJ, Ogbolu DO, Piddock LJV. Molecular mechanisms of antibiotic resistance. Nat Rev Microbio. 2015;13(1):42\u201351.","journal-title":"Nat Rev Microbio"},{"issue":"3","key":"1171_CR2","doi-asserted-by":"publisher","first-page":"a482","DOI":"10.4102\/ajlm.v5i3.482","volume":"5","author":"O Perovic","year":"2016","unstructured":"Perovic O, Schultsz C. Stepwise approach for implementation of antimicrobial resistance surveillance in Africa. Afr J Lab Med. 2016;5(3):a482. https:\/\/doi.org\/10.4102\/ajlm.v5i3.482.","journal-title":"Afr J Lab Med"},{"key":"1171_CR3","doi-asserted-by":"publisher","first-page":"267","DOI":"10.2471\/BLT.15.154666","volume":"94","author":"J Liu","year":"2016","unstructured":"Liu J, Prach LM, Treleaven E, Hansen M, Anyanti J, Jagha T, Seaman V, Ajumobie O, Isiguzoca C. The role of drug vendors in improving basic health-care services in Nigeria. Bull World Health Organ. 2016;94:267.","journal-title":"Bull World Health Organ"},{"issue":"3","key":"1171_CR4","first-page":"253","volume":"10","author":"AD Okonkwo","year":"2010","unstructured":"Okonkwo AD, Okonkwo UP. Patent medicine vendors, community pharmacists and STI management in Abuja, Nigeria. Afr Health Sci. 2010;10(3):253\u201365.","journal-title":"Afr Health Sci"},{"issue":"1","key":"1171_CR5","first-page":"169","volume":"3","author":"MM Yusha\u2019u","year":"2010","unstructured":"Yusha\u2019u MM, Aliyu HM, Kumurya AS, Suleiman L. Prevalence of extended spectrum beta lactamases among enterobacteriaceae in Murtala Muhammad Specialist Hospital, Kano, Nigeria. Bayero J Pure Appl Sci. 2010;3(1):169\u201377.","journal-title":"Bayero J Pure Appl Sci"},{"issue":"3","key":"1171_CR6","doi-asserted-by":"publisher","first-page":"62","DOI":"10.3923\/ijtmed.2010.62.64","volume":"5","author":"OA Olowe","year":"2010","unstructured":"Olowe OA, Aboderin BW. Detection of extended spectrum beta lactamase producing strains of (Escherichia coli)\u00a0and (Klebsiella\u00a0sp.) in a tertiary health centre in Ogun state. Int J of Trop Med. 2010;5(3):62\u20134.","journal-title":"Int J of Trop Med"},{"issue":"2","key":"1171_CR7","first-page":"DC07","volume":"10","author":"Y Mohammed","year":"2016","unstructured":"Mohammed Y, Gadzama GB, Zailani SB, Aboderin AO. Characterization of extended-spectrum beta-lactamase from Escherichia coli and Klebsiella Species from North Eastern Nigeria. J Clin Diagn Res. 2016;10(2):DC07-10.","journal-title":"J Clin Diagn Res"},{"key":"1171_CR8","doi-asserted-by":"publisher","first-page":"142","DOI":"10.3390\/antibiotics10020142","volume":"10","author":"KO Akinyemi","year":"2021","unstructured":"Akinyemi KO, Abegunrin RO, Iwalokun BA, Fakorede CO, Makarewicz O, Neubauer H, Pletz MW, Wareth G. The Emergence of Klebsiella pneumoniae with reduced susceptibility against third generation cephalosporins and carbapenems in Lagos Hospitals, Nigeria. Antibiotics. 2021;10:142. https:\/\/doi.org\/10.3390\/antibiotics10020142.","journal-title":"Antibiotics"},{"key":"1171_CR9","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s13756-020-00739-0","volume":"9","author":"EE Chukwu","year":"2020","unstructured":"Chukwu EE, Oladele DA, Awoderu OB, Afocha EE, Lawal RG, Abdus-salam I, et al. A national survey of public awareness of antimicrobial resistance in Nigeria. Antimicrob Resist Infect Control. 2020;9:72. https:\/\/doi.org\/10.1186\/s13756-020-00739-0.","journal-title":"Antimicrob Resist Infect Control"},{"issue":"10","key":"1171_CR10","doi-asserted-by":"publisher","first-page":"e51","DOI":"10.1093\/cid\/ciw118","volume":"62","author":"TF Barlam","year":"2016","unstructured":"Barlam TF, Cosgrove SE, Abbo LM, et al. Implementing an antibiotic stewardship program: guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America. Clin Infect Dis. 2016;62(10):e51-77.","journal-title":"Clin Infect Dis"},{"issue":"9","key":"1171_CR11","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.1093\/jac\/dku176","volume":"69","author":"SJ Leopold","year":"2014","unstructured":"Leopold SJ, van Leth F, Tarekegn H, et al. Antimicrobial drug resistance among clinically relevant bacterial isolates in sub-Saharan Africa: a systematic review. J Antimicrob Chemother. 2014;69(9):2337\u201353.","journal-title":"J Antimicrob Chemother"},{"key":"1171_CR12","unstructured":"Clinical Laboratory Standard Institute. Performance Standards for Antimicrobial Susceptibility Testing. 30th ed. CLSI supplement M100 (ISBN 978-1-68440-067-6): Clinical and Laboratory Standards Institute; 950 West Valley Road, Suite 2500, Wayne Pennsylvania 19087 USA, 2020."},{"key":"1171_CR13","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12941-015-0079-z","volume":"14","author":"NT Trung","year":"2015","unstructured":"Trung NT, Hien TTT, Huyen TTT, Quyen DT, Binh MT, Hoan PQ, Meyer CG, Velavan TP, Song LH. Simple multiplex PCR assays to detect common pathogens and associated genes encoding for acquired extended spectrum betalactamases (ESBL) or carbapenemases from surgical site specimens in Vietnam. Ann Clin Microbiol Antimicrob. 2015;14:23. DOI https:\/\/doi.org\/10.1186\/s12941-015-0079-z.","journal-title":"Ann Clin Microbiol Antimicrob"},{"issue":"3","key":"1171_CR14","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1128\/JCM.36.3.618-623.1998","volume":"36","author":"F Martineau","year":"1998","unstructured":"Martineau F, Picard FJ, Roy PH, Ouellette M, Bergeron MG. Species-specific and ubiquitous-DNA-based assays for rapid identification of Staphylococcus aureus. J Clin Microbiol. 1998;36(3):618\u201323. https:\/\/doi.org\/10.1128\/JCM.36.3.618-623.1998.","journal-title":"J Clin Microbiol"},{"key":"1171_CR15","doi-asserted-by":"publisher","first-page":"379","DOI":"10.2147\/IDR.S88725","volume":"8","author":"JA Opintan","year":"2015","unstructured":"Opintan JA, Newman MJ, Arhin RE, Donkor ES, Gyansa-Lutterodt M, Mills-Pappoe\nW. Laboratory-based nationwide surveillance of antimicrobial resistance in Ghana.\nInfection and Drug Resistance. 2015; 8: 379\u2013389.","journal-title":"Infect Drug Resist"},{"issue":"2","key":"1171_CR16","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1111\/j.1365-3156.2010.02695.x","volume":"16","author":"K Holloway","year":"2011","unstructured":"Holloway K, Mathai E, Gray A. Surveillance of community antimicrobial use in resource-constrained settings\u2013experience from five pilot projects. Trop Med Int Health. 2011;16(2):152\u201361.","journal-title":"Trop Med Int Health"},{"issue":"3","key":"1171_CR17","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1093\/cid\/ciu319","volume":"59","author":"EP Lesho","year":"2014","unstructured":"Lesho EP, Waterman PE, Chukwuma U, et al. The antimicrobial resistance monitoring and research (ARMoR) program: the US Department of Defense response to escalating antimicrobial resistance. Clin Infect Dis. 2014;59(3):390\u20137.","journal-title":"Clin Infect Dis"},{"key":"1171_CR18","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/2047-2994-2-31","volume":"2","author":"A Huttner","year":"2013","unstructured":"Huttner A, Harbarth S, Carlet J, et al. Antimicrobial resistance: a global view from the 2013 world healthcare-associated infections forum. Antimicrob Resist Infect Control. 2013;2:31.","journal-title":"Antimicrob Resist Infect Control"},{"key":"1171_CR19","unstructured":"WHO. World Health Organization. Antimicrobial Resistance: Global Report on Surveillance, Geneva; 2014. Available from: http:\/\/apps.who.int\/iris\/bitstream\/10665\/90975\/1\/WHO_HSE_PED_2013.10358_eng.pdf. Accessed 27 Apr\u00a0\u00a02014."},{"issue":"9","key":"1171_CR20","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1111\/1469-0691.12028","volume":"19","author":"ME de Kraker","year":"2013","unstructured":"de Kraker ME, Jarlier V, Monen JC, Heuer OE, van de Sande N, Grundmann H. The changing epidemiology of bacteraemias in Europe: trends from the European Antimicrobial Resistance Surveillance System. Clin Microbiol Infect. 2013;19(9):860\u20138.","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"1171_CR21","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1128\/JCM.38.1.7-12.2000","volume":"38","author":"IN Okeke","year":"2000","unstructured":"Okeke IN, Lamikanra A, Steinr\u00fcck H, Kaper JB. Characterization of Escherichia coli strains from cases of childhood diarrhea in provincial southwestern Nigeria. J Clin Microbiol. 2000;38(1):7\u201312.","journal-title":"J Clin Microbiol"},{"key":"1171_CR22","doi-asserted-by":"publisher","first-page":"147307","DOI":"10.1038\/s41598-020-70517-w","volume":"10","author":"JS Iramiot","year":"2020","unstructured":"Iramiot JS, Kajumbula H, Bazira J, Kansiime C, Asiimwe BB. Antimicrobial resistance at the human\u2013animal interface in the Pastoralist Communities of Kasese District, South Western Uganda. Sci Rep. 2020;10:147307. https:\/\/doi.org\/10.1038\/s41598-020-70517-w.","journal-title":"Sci Rep"},{"issue":"3","key":"1171_CR23","doi-asserted-by":"publisher","first-page":"135","DOI":"10.14194\/ijmbr.4.3.4","volume":"4","author":"EK Oladipo","year":"2015","unstructured":"Oladipo EK, Oloke JK, Omomowo IO, Oyeniran AO, Awoyelu EH, Ogundele SO. Incidence of cephalosporin resistance among clinical isolates of Pseudomonas aeruginosa in Ibadan, southwestern Nigeria. Int J Med Biomed Res. 2015;4(3):135\u201341.","journal-title":"Int J Med Biomed Res"},{"key":"1171_CR24","doi-asserted-by":"publisher","first-page":"142","DOI":"10.3390\/antibiotics10020142","volume":"10","author":"KO Akinyemi","year":"2021","unstructured":"Akinyemi KO, Abegunrin RO, Iwalokun BA, Fakorede CO, Makarewicz O, Neubauer H, Pletz MW, Wareth G. The Emergence of Klebsiella pneumoniae with reduced susceptibility against third generation cephalosporins and Carbapenems in Lagos Hospitals, Nigeria. Antibiotics. 2021;10:142.","journal-title":"Antibiotics"},{"key":"1171_CR25","doi-asserted-by":"publisher","first-page":"42","DOI":"10.4103\/atp.atp_38_17","volume":"8","author":"OO Oduyebo","year":"2017","unstructured":"Oduyebo OO, Olayinka AT, Iregbu KC, Versporten A, Goossens H, Nwajio-bi-Princewill PI, et al. A point prevalence survey of antimicrobial prescribing in four Nigerian tertiary hospitals. Ann Trop Pathol. 2017;8:42\u20136.","journal-title":"Ann Trop Pathol"},{"key":"1171_CR26","doi-asserted-by":"crossref","unstructured":"World Health Organization Model List of Essential Medicines\u201322nd List. 2021. Geneva: World Health Organization; 2021 (WHO\/MHP\/HPS\/EML\/2021.02). Licence: CC BY-NC-SA 3.0 IGO.","DOI":"10.1530\/ey.19.13.1"},{"issue":"1","key":"1171_CR27","doi-asserted-by":"publisher","first-page":"e2019041","DOI":"10.4084\/MJHID.2019.041","volume":"11","author":"AH Pishtiwan","year":"2019","unstructured":"Pishtiwan AH, Khadija Kh M. Prevalence of blaTEM, blaSHV, and blaCTX-M genes among ESBL-producing Klebsiella pneumoniae and Escherichia coli isolated from thalassemia patients in Erbil, Iraq. Mediterr J Hematol Infect Dis. 2019;11(1):e2019041. https:\/\/doi.org\/10.4084\/MJHID.2019.041.","journal-title":"Mediterr J Hematol Infect Dis"},{"issue":"1","key":"1171_CR28","doi-asserted-by":"publisher","first-page":"204","DOI":"10.3390\/molecules18010204","volume":"18","author":"N Koyama","year":"2012","unstructured":"Koyama N, Inokoshi J, Tomoda H. Anti-infectious agents against MRSA. Molecules. 2012;18(1):204\u201324.","journal-title":"Molecules"},{"issue":"3","key":"1171_CR29","doi-asserted-by":"publisher","first-page":"24","DOI":"10.5897\/JIDI2013.0118","volume":"5","author":"N Torimiro","year":"2013","unstructured":"Torimiro N. Analysis of Beta-lactamase production and antibiotics resistance in Staphylococcus aureus strains. J Infect Dis Immun. 2013;5(3):24\u20138.","journal-title":"J Infect Dis Immun"},{"key":"1171_CR30","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1155\/2019\/8321834","volume":"8321834","author":"EY Garoy","year":"2019","unstructured":"Garoy EY, Gebreab YB, Achila OO, Tekeste DG, Kesete R, Ghirmay R, Kiflay R, Tesfu T. Methicillin-resistant Staphylococcus aureus (MRSA): prevalence and antimicrobial sensitivity pattern among patients\u2014a multicenter study in Asmara, Eritrea. Can J Infectious Dis Med Microbiol. 2019;8321834:9. https:\/\/doi.org\/10.1155\/2019\/8321834.","journal-title":"Article ID"},{"key":"1171_CR31","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/2191532","author":"R Adhikari","year":"2017","unstructured":"Adhikari R, Pant ND, Neupane S, Neupane M, Bhattarai R, Bhatta S, Chaudhary R, Lekhak B. Detection of methicillin resistant Staphylococcus aureus and determination of minimum inhibitory concentration of vancomycin for Staphylococcus aureus isolated from pus\/wound swab samples of the patients attending a tertiary care hospital in Kathmandu, Nepal. Can J Infectious Dis Med Microbiol. 2017. https:\/\/doi.org\/10.1155\/2017\/2191532.","journal-title":"Can J Infectious Dis Med Microbiol"},{"key":"1171_CR32","unstructured":"Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: twenty third informational supplement edition. CLSI DocumentM100-S23, CLSI,Wayne, Pa, USA, 2013."},{"issue":"1","key":"1171_CR33","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1128\/JCM.01507-09","volume":"48","author":"JH Jorgensen","year":"2010","unstructured":"Jorgensen JH, McElmeel ML, Fulcher LC, Zimmer BL. Detection of CTX-M-type extended-spectrum beta-lactamase (ESBLs) by testing with MicroScan overnight and ESBL confirmation panels. J Clin Microbiol. 2010;48(1):120\u20133. https:\/\/doi.org\/10.1128\/JCM.01507-09.","journal-title":"J Clin Microbiol"},{"issue":"4","key":"1171_CR34","first-page":"1257","volume":"14","author":"S Ghorbani-Dalinia","year":"2015","unstructured":"Ghorbani-Dalinia S, Kargarb M, Doostic A, Abbasid P, Sarshare M. Molecular epidemiology of ESBLs genes and multi-drug resistance in diarrheagenic Escherichia Coli strains isolated from adults in Iran. Iran J Pharm Res. 2015;14(4):1257\u201362.","journal-title":"Iran J Pharm Res"},{"issue":"1","key":"1171_CR35","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.diagmicrobio.2016.10.007PMid:27773544","volume":"87","author":"K Liao","year":"2017","unstructured":"Liao K, Chen Y, Wang M, Guo P, Yang Q, Ni Y, Yu Y, Hu B, Sun Z, Huang W. Molecular characteristics of extended-spectrum \u03b2-lactamaseproducing Escherichia coli and Klebsiella pneumoniae causing intraabdominal infections from 9 tertiary hospitals in China. Diagn Microbiol Infect Dis. 2017;87(1):45\u20138. https:\/\/doi.org\/10.1016\/j.diagmicrobio.2016.10.007PMid:27773544.","journal-title":"Diagn Microbiol Infect Dis"},{"key":"1171_CR36","doi-asserted-by":"publisher","first-page":"179","DOI":"10.4103\/smj.smj_17_17","volume":"21","author":"Y Mohammed","year":"2018","unstructured":"Mohammed Y, Ibrahim BS, Galalain SM, Dalhat MM, Nguku P. Antimicrobial resistance surveillance system in Nigeria: suggested models. Sahel Med J. 2018;21:179\u201380.","journal-title":"Sahel Med J"}],"container-title":["Antimicrobial Resistance &amp; Infection Control"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13756-022-01171-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13756-022-01171-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13756-022-01171-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,8]],"date-time":"2022-11-08T07:50:55Z","timestamp":1667893855000},"score":1,"resource":{"primary":{"URL":"https:\/\/aricjournal.biomedcentral.com\/articles\/10.1186\/s13756-022-01171-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,8]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["1171"],"URL":"https:\/\/doi.org\/10.1186\/s13756-022-01171-2","relation":{},"ISSN":["2047-2994"],"issn-type":[{"value":"2047-2994","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,8]]},"assertion":[{"value":"9 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical clearance was obtained from Nigerian Institute of Medical Research Institutional Review Board (IRB\/19\/022). Also, social permission to conduct this study was obtained from Lagos State Ministry of Health (LSMH\/2695\/II\/141) and Lagos State Health Service commission (SHSC\/2222\/VOL.1\/49). All participants willingly signed an informed consent form before demographic information was obtained from them using a questionnaire. Information obtained from the patients were treated as confidential. Unique identifiers were used to identify the samples and data management protocols were followed.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"134"}}